Kyntra Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kyntra Bio and other ETFs, options, and stocks.About KYNB
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.
CEOThane Wettig
CEOThane Wettig
Employees225
Employees225
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1993
Founded1993
Employees225
Employees225
KYNB Key Statistics
Market cap28.18M
Market cap28.18M
Price-Earnings ratio0.17
Price-Earnings ratio0.17
Dividend yield—
Dividend yield—
Average volume29.52K
Average volume29.52K
High today$7.24
High today$7.24
Low today$6.92
Low today$6.92
Open price$7.12
Open price$7.12
Volume19.83K
Volume19.83K
52 Week high$12.60
52 Week high$12.60
52 Week low$4.85
52 Week low$4.85
Stock Snapshot
As of today, Kyntra Bio(KYNB) shares are valued at $6.97. The company's market cap stands at 28.18M, with a P/E ratio of 0.17.
As of 2026-03-14, Kyntra Bio(KYNB) stock has fluctuated between $6.92 and $7.24. The current price stands at $6.97, placing the stock +0.7% above today's low and -3.7% off the high.
Kyntra Bio(KYNB) shares are trading with a volume of 19.83K, against a daily average of 29.52K.
During the past year, Kyntra Bio(KYNB) stock moved between $4.85 at its lowest and $12.60 at its peak.
During the past year, Kyntra Bio(KYNB) stock moved between $4.85 at its lowest and $12.60 at its peak.
People also own
Based on the portfolios of people who own KYNB. This list is generated using Robinhood data, and it’s not a recommendation.